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Abstract Biodegradable collagen matrices have become a
promising alternative to synthetic polymers as drug deli-
very systems for sustained release. Previously, a mathema-
tical model describing water penetration, matrix swelling
and drug release by diffusion from dense collagen matrices
was introduced and tested (cf. Radu et al. in J. Pharm. Sci.
91:964–972, 2002). However, enzymatic matrix degradation
influences the drug release as well. Based on experimental
studies (cf. Metzmacher in Enzymatic degradation and drug
release behavior of dense collagen implants. Ph.D. thesis,
LMU University of Munich, 2005), a mathematical model is
presented here that describes drug release by collagenolytic
matrix degradation. Existence and uniqueness of a solution of
the model equations is reviewed. A mixed Raviart–Thomas
finite element discretization for solving the coupled system
of partial and ordinary differential equations is proposed and
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analyzed theoretically. The model is verified by a comparison
of numerically calculated and experimentally measured data
and, in particular, investigated by a parameter sensitivity
study. For illustration, some concentration profiles of a two-
dimensional simulation are shown.
1 Introduction
Collagen is the major constituent of connective tissue; cf. [8].
Due to its wide distribution in the mammalian body, it has
become a promising material for biodegradable drug deli-
very systems. Dense collagen matrices for sustained release
of higher weight drugs such as proteins or polysaccharides
offer an alternative to implants based on synthetic polymers;
cf. [8]. Especially drug release from insoluble collagen
devices is of interest since drug liberation can be controlled
by swelling and enzymatic degradation. Initially the matrix
swells and drug is released by diffusion. This phenomenon
was described previously in a mathematical model; cf. [18].
Subsequently, degradation by collagenolytic enzymes occurs
and the release rate becomes additionally dependent on the
enzymatic binding and cleavage rate.
For designing and optimizing such biodegradable drug
delivery systems there is a strong need of mathematical
models that describe both, matrix degradation and drug
release, by considering all the relevant processes occuring.
In a recent work of the authors, the enzymatically catalyzed
matrix degradation and simultaneous drug delivery was stu-
died experimentally by measurements; cf. [15,16]. Based on
these experimental investigations, a mathematical model was
formulated and validated by a comparison of measurements
and numerical calculations. Other models that were publi-
shed in the literature to describe collagen matrix degradation
and drug release either oversimplify (cf. [12,22]) or are less
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complete than the model that is given in Sect. 2. In [24],
Tzafriri et al. suggest a model for enzymatic matrix degrada-
tion that is similar in complexity with the one given here, but
the authors describe the matrix degradation differently and,
moreover, do not consider the drug release.
Whereas in [16] we focused on experimental investiga-
tions of the material and the identification of all relevant pro-
cesses, in this work the mathematical model and numerical
techniques for solving the equations are considered more in
detail. In particular, for the mathematical model the existence
and uniqueness of a solution is reviewed and an error esti-
mate is proved for a Raviart–Thomas mixed finite element
discretization scheme that is applied here. The latter is done
for a semilinear model problem that is of the same mathe-
matical structure as the governing equations of the overall
system. The innovation of the error analysis consists in the
occurance and treatment of a nonlinear reaction term r(c) for
the specie’s concentration c with unbounded derivative r ′(·).
Only a Hölder condition is imposed on r(·). Moreover, to
verify our model, a comparison of measurements and nume-
rical calculations is done and the sensitivity of the mathema-
tical model with respect to some input parameters that are
material dependent and have to be prescribed is investigated.
The sensitivity study is done by two- and three-dimensional
computations.
The paper is organized as follows. Our mathematical
model for enzymatic matrix degradation and drug delivery
is introduced in Sect. 2. The discretization scheme that we
use to solve the set of partial and ordinary differential equa-
tions is described and analyzed theoretically in Sect. 3. In
Sect. 4, a computational investigation of the mathematical
model is presented. In particular, the sensitivity of relevant
quantities with respect to some model parameters is studied
numerically and, moreover, the numerically calculated data
are compared with experimentally determined data. Further,
the convergence behaviour of the numerical discretization
scheme is analyzed for a model problem. We end this work
with some conclusions in Sect. 5.
2 Mathematical model
Drug release from dense collagen matrices as carrier
systems for higher weight drugs is controlled by swelling and
enzymatic degradation of the matrices; cf. [8,15,16]. Firstly,
collagen is a hydrogel and swells after contact with aqueous
solutions such that drug liberation by diffusion occurs. This
mechanism was studied in a former work (cf. [18]) and is not
considered here. Secondly, drug delivery systems containing
collagen are degraded by collagenolytic enzymes such that
the drug liberation becomes dependent on the enzyme bin-
ding and cleavage rate. This mechanism shall be described
mathematically and simulated in the sequel. Separating the
either mechanisms of drug release in their investigation,
mathematical modelling and numerical simulation seems rea-
sonable since they proceed on strongly different time scales,
as our experimental studies have borne out; cf. [15]. Whe-
reas drug release due to swelling is restricted to an initial
period of some minutes (up to 30 min approximately), drug
release by matrix degradation takes place over several days
(up to 14 days possibly). The approach to separate the either
mechanisms enabled us to apply more adapted mathema-
tical and numerical methods to the separated subprocesses.
An overall mathematical model combining the model
components—drug release by swelling and drug release by
matrix degradation—will be studied in a future work.
Therefore, from now on we assume a fully swollen carrier
matrix along with an aqueous drug solution that is incorpora-
ted in the collagen fibre mesh. The hydrolytic degradation of a
solid polymer matrix can occur by two extreme mechanisms.
In the first one, refered to as heterogeneous, degradation is
confined to the surface of the device and the undegraded
carrier retains its chemical integrity during the process. In
the other one, called homogeneous, hydrolysis involves ran-
dom cleavage at a uniform rate throughout the bulk of the
matrix. While the molecular weight of the polymer steadily
decreases, the carrier can remain essentially intact until the
polymer has undergone signifiant degradation, and reaches a
critical molecular weight at which solubilization starts.
Based on our experimental observations (cf. [15,16]), we
assume homogeneous degradation. Thus, the relevant pro-
cesses to be described now are
– the diffusion of the enzyme in the swollen collagen matrix,
– the adsorption of the enzyme from the fluid to the collagen
fibers,
– the enzymatic degradation of the polymer
– and, finally, the drug release.
The common reaction scheme for an enzymatically
catalyzed degradation of a substrate was proposed by
Michaelis and Menten (cf. [7]) and is given by
E + S k1−→ ES (2.1)
and
ES k2−→ E + P, (2.2)
where E is the enzyme, S the subtrate, ES the enzyme-
substrate complex and P denotes the product. In the appli-
cation under consideration, collagen represents the substrate
whereas the hydrolyzed collagen is the product. Further,
k1 and k2 denote rate parameters where k1 describes the
adsorption of enzyme onto the active binding site of the col-
lagen fibre and k2 characterizes the cleavage process. The
first of the either reactions represents the adsorption process
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and the second one describes the cleavage of the substrate
complex into a product and enzyme. The adsorption may be
considered either as an equilibrium process or a kinetic one,
depending on its time scale compared to the diffusion pro-
cess. In the sequel, we will describe the adsorption of enzyme
onto the collagen fibers as a kinetic reaction by means of a
Freundlich-type isotherm which is based on our experimen-
tal investigations; cf. [15,16]. This is in agreement with [21],
where also a Freundlich-type isotherm is proposed.
Assuming further that the diffusion of the enzyme in the
swollen matrix is of Fickian type, our model equations des-
cribing the enzymatic collagen matrix degradation by means
of (2.1), (2.2) then read as
∂t CE − ∇ · (DE (CK )∇CE ) + kactCE
= −k1(CE )αCK + k2CγE S, (2.3)
∂t CE S = k1(CE )αCK − k2CγE S, (2.4)
∂t CK = −k1(CE )αCK , (2.5)
and
∂t CP − ∇ · (DP∇CP ) = k2CγE S . (2.6)
We consider solving (2.3)–(2.6), equipped with the initial
conditions
CE (·, 0) = 0, CE S(·, 0) = 0,
CK (·, 0) = C0K , CP (·, 0) = 0
(2.7)
and the boundary conditions
CE (·, t) = CextE , CP (·, t) = 0, for t > 0, (2.8)
on Ω × (0, T ], where Ω ⊂ Rd with d = 2 or d = 3
is the polymer matrix and T > 0. Clearly, (2.7) is satis-
fied for all x ∈ Ω and (2.8) for all x ∈ Γ = ∂Ω where
Γ denotes the boundary of Ω . In (2.3), (2.4), the variables
CE , CE S denote the concentrations, expressed in moles per
volume, of the free enzyme and the enzyme–collagen com-
plex, respectively. The variable CP denotes the concentration
of the degradation product (hydrolyzed collagen), which is
free to diffuse out of the polymer matrix. The enzyme acti-
vity decays in time which is incorporated in (2.3) by means
of the term kactCE , with kact being a dimensionless constant
that has to be determined experimentally. In (2.3)–(2.5), the
quantity α denotes the parameter of the Freundlich isotherm
and k1, k2 are the rate parameters of (2.1), (2.2). In particu-
lar, α ∈ (0, 1] is satisfied. We note that in our simulation
software a more general functional form is implemented for
the rate r describing the adsorption process (i.e., for the first
term on the right-hand side of (2.3) and (2.4), respectively),
namely, r = −k1φ(CE )CδK where φ(·) can be chosen as a
linear, Freundlich, Langmuir or Freundlich–Langmuir type
isotherm and δ is a dimensionless parameter. In this paper,
we use a Freundlich isotherm and set δ = 1, which is done
due to our experimental oberservations; cf. [16]. Comparing
our numerically calculated results with the measured data
has shown that a nonlinear dependence of the right-hand
side terms in (2.3)–(2.6) on CE S is necessary to describe
adequately the enzymatic matrix degradation by the set of
Eqs. (2.3)–(2.6). Thus, the parameter γ > 0 is of empirical
origin. In Sect. 4, the sensitivity of the calculated results with
respect to γ is studied carefully.
In (2.7), C0K denotes the collagen concentration at the
initial time. In (2.8), CextE is the enzyme concentration in
the ambient aqueous solution that has to be prescribed. Due
to the degradation process occuring concurrently, the matrix
phase through which the diffusion takes place changes conti-
nuously as a function of the extend of hydrolysis of the poly-
mer. Therefore, the diffusion coefficient DE of the enzyme
cannot be considered as a constant but rather has to be consi-
dered as a function of the fluid or collagen concentration.
Here, we assume a Fujita-like dependence (cf. free volume
theory in [9]) on the concentration of the collagen CK , i.e.,
DE = D0E exp(−βE CKC0K ), with D
0
E denoting the diffusion
coefficient of the enzyme in water and βE denoting a dimen-
sionless constant. The diffusion coefficient DP of the product
in the ambient fluid is assumed to be a constant which does
not seem to be strongly limiting. The parameters D0E and DP
can be determined by measurements; cf. [15,16].
A direct consequence of the assumption of homogeneous
degradation and of the model Eqs. (2.3)–(2.8) is that the
degradation of the polymeric substrate by the enzyme is inde-
pendent of the active agent or drug, respectively. To model
drug release, we assume (as also done, for instance, in [23])
that the initial load of active agent is composed of two pools:
a pool of mobile active agent which is free to diffuse upon
hydration of the matrix by the ambient aqueous solution,
and some part which is immobilized by the polymer and can
diffuse only after the degradation of the matrix. The immo-
bilization of the active agent is due to physical entrapment
only.
In our mathematical model we describe the release of the
active agent by a diffusion equation with a source term that
models the liberation of the immobilized active agent by
matrix degradation. Precisely, the equation reads as
∂t CA − ∇ · (DA(CK )∇CA) = −∂t CAi (2.9)
where CA, CAi denote the concentrations of free and
immobilized drug, respectively. We equip Eq. (2.9) with the
initial and boundary condition
CA(·, 0) = C0A in Ω,
CA(·, t) = 0 on Γ, for t > 0.
(2.10)
The initial concentration C0A of the active agent that is free
to diffuse can be determined experimentally by measuring
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the quantity of drug which would remain in the matrix if
no degradation occurs, i.e., if no enzyme is available. To
complete our model, a functional dependence of CAi on CA
is still needed. We assume that
CAi = σCηK , (2.11)
where σ ≥ 0 and η > 0 are empirical parameters that have
to be prescribed. In [23], it is simply assumed that CAi =
σCK where σ is a dimensionless constant that denotes the
immobilizing capacity of the polymer and is equal to the
number of hindering crosslinks or entanglements per mole of
(fully swollen) substrate. The more general functional form
(2.11) is based on our experimental observations; cf. [15,
16]. They have shown that the dependence of the released
active agent on the collagen is nonlinear. The parameter η
is studied further in Sect. 4. Similarly to the enzyme, for
the diffusion coefficient of the active agent in the matrix a
functional form DA = D0Aexp(−βACKC0K ) is used, where D
0
A
denotes the diffusion coefficient of the drug in the undegraded
matrix, C0K is the initial concentration of collagen and βA is
a dimensionless constant; cf. [9,22].
Mathematically, we are thus faced with solving a non-
linear system of partial and ordinary differential equations
that is given by (2.3)–(2.11). Concerning the existence and
uniqueness of solutions of the Eqs. (2.3)–(2.11) the following
result can directly be stated if the nonlinear dependence of
the diffusion coefficients DE and DA on CK is neglected.
Theorem 1 Suppose that Ω ⊂ R2 with ∂Ω ∈ C1,1. Let
p > 2 and C0A ∈ W 2−2/pp (Ω), C0A ≥ 0 in Ω , and C0K ∈
C(Ω), C0K ≥ 0 in Ω , be satisfied. Suppose that CextE ∈
W 2−1/p,1−1/2pp (ΓT ) and CextE ≥ 0 on ΓT = Γ × (0, T ). Let
α ∈ (0, 1], γ ∈ (0, 2] and η > 0 be satisfied. Then, for any
given T ∈ (0,∞) the system of Eqs. (2.3)–(2.11) admits an
unique nonnegative solution
CE ∈ W 2,1p (QT ), CP ∈ W 2,1p (QT ), CA ∈ W 2,1p (QT ),
p > 2, CE S ∈C1([0, T ]; C(Ω)), CK ∈C1([0, T ]; C(Ω)).
(2.12)
In (2.12), we use the abbreviation QT = Ω × (0, T ).
The notation of the space-time function spaces is standard;
cf., e.g., [11]. We note that even the nonnegativeness of the
species is ensured in Theorem 1. Essentially, Theorem 1 can
be proved along the lines of [13], where for a model that is
of a similar mathematical structure as the Eqs. (2.3)–(2.11)
the existence and uniqueness of a solution is shown; cf. also
[4,14]. The existence proof is based on the fixed-point theo-
rem of Leray and Schauder. Restricting the range of the para-
meter γ to the interval (0, 2] does not seem to be strongly
limiting for our application; cf. Sect. 4. For a larger range of
parameters γ the local existence and uniqueness of a nonne-
gative solution to (2.3)–(2.11) can at least still be proved by
a fixed-point argument of Schauder. Similarly, for the three-
dimensional case Ω ⊂ R3 the local existence and uniquess
of a nonnegative solution can be ensured.
3 Discretization techniques
We shall now describe briefly the discretization techniques
that we apply to solve the Eqs. (2.3)–(2.11) numerically. Our
numerical approach is based on the mixed finite element
method (MFEM); cf. [5,19]. We use a simulator that was ori-
ginally developed at the Institute for Applied Mathematics
of the University of Erlangen–Nürnberg for investigating
reactive solute transport in the subsurface (cf. [19]) and was
implemented in the software toolbox ug (version 3.8);
cf. [2].
More precisely, we use the backward Euler scheme for
the temporal discretization of (2.3)–(2.11) and the lowest
order Raviart–Thomas mixed finite elements for the spa-
tial approximation; cf. [3,5,19]. Appreciable advantage of
the MFEM is its local mass conservation property and that
the fluxes over interelement boundaries remain continuous.
Since the Eqs. (2.3)–(2.6) are coupled to each other, they
are solved simultaneously by a damped version of Newton’s
method. For solving the linear system of the Newton iteration
a multigrid algorithm is applied; cf. [3]. Since (2.3)–(2.6)
do not depend on the active agent CA, Eq. (2.9) is solved
subsequently before proceeding to the next time step. Equa-
tion (2.9) could also be solved together with (2.3)–(2.6). The
separation of (2.9) from (2.3)–(2.6) was only done for imple-
mentational reasons.
We shall now present briefly the algebraic systems that
arise from discretizing (2.3)–(2.11) by the backward Euler
scheme and the Raviart–Thomas lowest order mixed finite
elements and need to be solved in each time step. Firstly, we
rewrite the partial differential equations (2.3), (2.6) and (2.9)
as first order systems of equations by introducing the flux
variables qE , q P and q A of the free enzyme, the product and
the active agent, respectively, as additional unknowns. Thus,
we get that
∂t CE + ∇ · qE + kactCE = −RE (CE , CE S, CK ), (3.1)
qE = −DE∇CE , (3.2)
∂t CP + ∇ · q P = RP (CE S), (3.3)
q P = −DP∇CP , (3.4)
∂t CA + ∇ · q A = σηCK (η−1) RK (CE , CK ), (3.5)
q A = −DA(CK )∇CA, (3.6)
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and from (2.4), (2.5)
∂t CE S = RE (CE , CE S, CK ),
∂t CK = −RK (CE , CK ),
(3.7)
where
RK (CE , CK ) = k1(CE )αCK , (3.8)
RP (CE S) = k2CγE S, (3.9)
RE = RK (CE , CK ) − RP (CE S). (3.10)
In the sequel we need further notations. Let t0 < t1 < · · · <
tN with t0 = 0 and tN = T denote the grid for the time
variable t on the interval [0, T ] with step size τn = tn −
tn−1. L2(Ω) and L2(Ω) are the spaces of all strongly mea-
surable, square integrable, scalar-valued and vector-valued
functions on Ω , respectively, and H (div;Ω) is the space of
all L2-vector functions with divergence in L2(Ω). Let
Th = {T } be a decomposition of Ω ⊂ Rd into triangles or
tetrahedrons, respectively. The decomposition is assumed to
be face to face. By Sh we denote the set of all faces of Th . We
compute approximations of the variables in the L B B-stable
pair of finite element spaces Wh×V h ⊂ L2(Ω)×H (div;Ω),
where
Wh = {wh ∈ L2(Ω) | wh is constant on T,∀T ∈ Th}
and
V h = {q ∈ H (div;Ω) | q(x)|T = a + bx,
x ∈ T, a ∈ Rd , b ∈ R, ∀T ∈ Th}.
V h is the lowest order Raviart–Thomas space; cf. [5]. Conse-
quently, for the concentrations of the free enzyme, the
enzyme–substrate complex, the collagen, the product and
the active agent we consider determining approximations
CET, CEST, CKT, CPT and CAT that are constant on each ele-
ment T . This yields one degree of freedom per specie and
element. The solutions of the ordinary differential equations
(2.4) and (2.5) are thus approximated also in Wh . The degrees
of freedom of fluxes vh ∈ V h are their normal components
vh · ν on the faces S ∈ Sh . Hence, for the fluxes q i , i =
E, P, A, we get one degree of freedom qi,S , i = E, P, A, on
each face S ∈ Sh . For further characterizations of the spaces
Wh and V h we refer to [5].
However, applying the mixed finite element method in
its dual formulation to the time discrete versions of (3.1)–
(3.7) leads to indefinite systems of equations such that stan-
dard iterative linear solvers cannot be applied; cf. [5] for the
linear case and [3,19] for nonlinear problems. To overcome
this drawback of the MFEM, we use a hybrid variant of the
approach by introducing Lagrange multipliers; cf. [5]. For
the application of this technique in a nonlinear framework
we refer, in particular, to [3,19]. The Lagrange multiplier
technique allows us to relax the continuity constraint on the
normal components of the fluxes over interelement faces,
which is implied by q i ∈ H (div;Ω) for i = E, P, A,
to requiring that only q i ∈ H(div; T ) is satisfied for all
T ∈ Th . Then, the continuity of the normal fluxes is respecti-
vely ensured by an additional variational equation involving
the Lagrange multipliers λE , λP and λA that are defined on
the faces and are piecewise constant there, i.e., λE , λP , λA ∈
Λh = {λ ∈ L2(Sh) | λ|S = constant ∀S ∈ Sh}. After an
elimination of internal degrees of freedom, also known as
static condensation, the degrees of freedom λE S, λP S and
λAS of the Lagrange multipliers become the unknowns of a
global nonlinear system of equations which we solve by New-
ton’s method and a multigrid algorithm as mentioned before;
cf. [3,19] for technical details. Precisely, for each of the spe-
cies enzyme, product and active agent we get one degree of
freedom per face which can also be considered as an approxi-
mation of the concentration profile on the interelement face
and, moreover, as a degree of freedom of a second order
accurate nonconforming Crouzeix–Raviart discretization of
the concentratio n profile; cf. [5] for details.
Then the nonlinear algebraic problem that has to be solved
at time tn , n = 1, . . . , N , for the transport of enzyme and the





PT find CnET, CnEST,CnKT, CnPT, λnE S, λnP S and
qnE,T S, q
n






qnE,T S + τnkactCnET
= Cn−1ET − τn RE (CnET, CnEST, CnKT), (3.11)
CnEST − Cn−1EST = τn RE (CnET, CnEST, CnKT), (3.12)






qnP,T S = Cn−1PT + τn RP (CnEST), (3.14)
∑
S′⊂T
BT SS′qnE,T S′ = DE (CnET − λnE S), (3.15)
∑
S′⊂T
BT SS′qnP,T S′ = DP (CnPT − λnP S), (3.16)
qnE,T S = −qnE,T ′S, (3.17)
qnP,T S = −qnP,T ′S . (3.18)
Equations (3.11)–(3.14) have to be satisfied for all T ∈ Th ,
Eqs. (3.15), (3.16) have to be fulfilled for all T ∈ Th and
S ⊂ ∂T and, finally, the continuity constraints (3.17), (3.18)
are required for all S ∈ Sh where S ⊂ ∂T and S ⊂ ∂T ′
is assumed. In (3.11)–(3.18), we equipped the degrees of
freedom of the flux variables with an additional index T , i.e.,
we write qni,T S instead of q
n
i,S , for i = E, P . This is only
done for the hybridization of the mixed finite approximation
of (3.1), (3.3) and the resulting elementwise formulation of
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the constraints. In (3.11)–(3.16), VT denotes the volume of




vT S · vT S′ dx,
where vT S, vT S′ are the local basis functions of the lowest
order Raviart–Thomas space on the element T with respect to
the faces S and S′; cf. [3,5]. The Dirichlet boundary condi-
tions (2.8) are incorporated in the discrete scheme (3.11)–
(3.18) in the usual way by putting λni,S = |E |−1
∫
E Ci (·, tn)
dσ for E ⊂ Γ , i = E, P; cf. [3,5,19]. For details of the
elimation of internal degrees of freedom in (3.11)–(3.18)
and the solution of resulting nonlinear global system for the
Lagrange multipliers by Newton’s method we refer to the
literature; cf. [3,19].
Similarly, once the collagen concentration at time tn , n =
1, . . . , N has been computed, the drug concentration profile
at tn is calculated by solving the following discrete problem:
for given Cn−1AT , CnET, CnKT find CnAT, λnAS and qnA,T S such that
it holds that










= DA(CnKT)(CnAT − λnAS), (3.20)
qnA,T S = −qnA,T ′S . (3.21)
Again, the Eqs. (3.19)–(3.21) are to be satisfied for all T ∈
Th , for all T ∈ Th , S ⊂ ∂T and for all S ∈ Sh with S ⊂ ∂T ,
S ⊂ ∂T ′, respectively.
A crucial point in the numerical analysis of the discretiza-
tion scheme (3.11)–(3.18) is the occurance of reaction terms
that are of the form Cαi , i = E, E S, K , with a parameter
α that may be less than one, i.e., α ∈ (0, 1). For functions
r(c) = cα with α ∈ (0, 1) the derivatives r ′(c) = αcα−1
become unbounded if c converges to 0 which makes difficul-
ties in the error analysis, as we shall see below. Parameters
α ≥ 1 are less crucial in this respect and, therefore, not stu-
died here. Thus, in the sequel we shall show for the semilinear
model problem
− ∆c + r(c) = f in Ω, c = 0 on ∂Ω (3.22)
that under the assumptions that
r ∈ C1 is nondecreasing and (3.23)
|r(c1) − r(c2)| ≤ L|c1 − c2|α (3.24)
is satisfied for some parameter α ∈ (0, 1), the convergence
of the lowest order Raviart–Thomas mixed finite element
approximation is ensured. But, the convergence is only sub-
optimal of the order 1+α2 instead of the order 1. In (3.22),
Ω ⊂ Rd is a bounded domain with Lipschitz–continuous
boundary ∂Ω . Considering the steady model problem (3.22)
instead of the full set of equations, allows us to avoid tech-
nical overhead and reduce the error analysis to its essential
elements. By the techniques developed in [20] the error ana-
lysis can be extended easily to the unsteady counterpart of
problem (3.22).
Analyzing the mixed finite element discretization of
problem (3.22)–(3.24) differs from former publications inso-
far as we impose here weaker assumptions on the parame-
trization r(·) of the reaction term. Only the boundedness of
r(·) and its Hölder continuity (3.24) is assumed. For instance,
Chen [6] analyses an expanded MFEM under the assump-
tion that the parametrization of the reaction term is twice
continuously differentiable with bounded derivatives through
second order. However, this condition does not apply to our
model (2.3)–(2.11) with the reaction term being defined by
(3.8) with α ∈ (0, 1).
The mixed finite element approximation of (3.22)
then reads as follows: for given f ∈ L2(Ω) find {c, q} ∈
L2(Ω) × H (div;Ω) such that it holds that
〈∇ · q, w〉 + 〈r(c), w〉 = 〈 f, w〉, (3.25)
〈q, v〉 − 〈c,∇ · v〉 = 0 (3.26)
for all w ∈ L2(Ω) and v ∈ H (div;Ω).
The corresponding discrete variational formulation reads
as follows: for given f ∈ L2(Ω) find {ch, qh} ∈ Wh × V h
such that it holds that
〈∇ · qh, wh〉 + 〈r(ch), wh〉 = 〈 f, wh〉, (3.27)
〈qh, vh〉 − 〈ch,∇ · vh〉 = 0 (3.28)
for all wh ∈ Wh and vh ∈ V h .
In the sequel, we denote by Ph : L2(Ω) → Wh and Πh :
H (div;Ω) → V h , the standard interpolation operators; cf.
[17]. In particular, Ph and Πh satisfy
‖w − Phw‖L2(Ω) ≤ Ch‖w‖H1(Ω),
(3.29)‖v − Πhv‖L2(Ω) ≤ Ch‖v‖H 1(Ω)
for all w ∈ H1(Ω) and v ∈ H 1(Ω), respectively. The
definition of the spaces H1(Ω) and H 1(Ω) is standard; cf.,
e.g., [1,5].
For the scheme (3.27) and (3.28) the following error
estimate holds.
Theorem 2 Suppose that (c, q) ∈ W ×V solves (3.25) and
(3.26). Let (ch, qh) ∈ Wh × V h satisfy (3.27) and (3.28).
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Then we have that






with C denoting a generic constant, not depending on the
mesh size h.
Proof Substracting (3.27) and (3.28) from (3.25) and (3.26),
respectively, we obtain that
〈∇ · (q − qh), wh〉 + 〈r(c) − r(ch), wh〉 = 0, (3.31)
〈q − qh, vh〉 − 〈c − ch,∇ · vh〉 = 0 (3.32)
for all wh ∈ Wh and vh ∈ V h , respectively. We recall that
∇ · vh ∈ Wh such that 〈c − ch,∇ · vh〉 = 〈Phc − ch,∇ ·
vh〉. Further, by the definition of Πh , it holds that 〈∇ · (q −
qh), wh〉 = 〈∇ · (Πq − qh), wh〉. Then, choosing wh =
Phc − ch and vh = Πhq − qh and adding the resulting
equations we get that
〈r(c)−r(ch), Phc−ch〉+〈q − qh,Πhq−qh〉 = 0. (3.33)
From (3.33) we deduce that
〈r(c) − r(ch), c − ch〉 + ‖q − qh‖2L2(Ω)
= 〈q − qh, q − Πhq〉 + 〈r(c)−r(ch), c−Phc〉. (3.34)
Since r(·) is a nondecreasing function by means of (3.23),
the first of the either terms on the left-hand side of (3.34) is
positive. By (3.24) it holds that












In (3.35), L is the constant of the Hölder-continuity condition
(3.24). For the first of the either terms on the right-hand side
of (3.34) we have that






‖q − Πhq‖2L2(Ω). (3.36)
Using the Cauchy–Young inequality, i.e., ab ≤ p−1a p +
q−1bq for a, b > 0 and p, q ∈ (1,∞) with p−1 + q−1 = 1,
with a = δ|r(c) − r(ch)|, b = δ−1|c − Phc| and p = (1 +
α)α−1 we observe that the second of the either right-hand
side terms in (3.34) is bounded through

































By a suitable choice of δ we then obtain from (3.34)–(3.37)
that
〈r(c) − r(ch), c − ch〉 + ‖q − qh‖2L2(Ω)
≤ C‖q − Πhq‖2L2(Ω) + C‖c − Phc‖
1+α
L1+α(Ω). (3.38)
Finally, we combine (3.38) with (3.29) and use the Sobolev
embedding of L2(Ω) in L1+α(Ω) for α ∈ (0, 1); cf. [1, p.
25, Theorem 2.8]. This proves the assertion (3.30). unionsq












4 Parameter sensitivity studies and computational
investigations
In this section we shall present some of our numerical results
and investigations to demonstrate the capability of the mathe-
matical model to describe reliably enzymatically catalyzed
degradation of collagen matrices and simultaneous drug deli-
very. In particular, we shall analyze the sensitivity of the cal-
culated characteristic quantities with respect to the model
parameters α and γ . These crucial parameters characterize
the degree of nonlinearity in the binding of the enzyme at
the collagen substrate and in the degradation of the collagen
by cleavage of the fibers. Further, we investigate numeri-
cally the influence of the matrix dimension on the enzymatic
degradation and drug release process. Cylindrical matrices
are considered for which two and three dimensional compu-
tations were performed. The set of parameters that was used
for the calculations is summarized in Table 1. Most of these
parameters were determined by measurements. The values
given in Table 1 for α, γ and η were determined in [16]
by least-squares fitting and have to be considered as best-fit
numbers. For further details, also for a precise characteriza-
tion of the compounds (collagenous material and drug FITC
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Table 1 Parameters of the
numerical simulations; cf. [16] Collagen degradation Drug release
R 0.139 cm D0E 2.410−3 cm2/h D0A 1.3710−3 cm2/h
βE 0.5 DP 2.410−3 cm2/h βA 0.5
C0K 1.12 µmol/cm
3 CextE 1.4 10−6 µmol/cm3 C0A 0
kact 0 k1 4579 cm3/(µmol h) C0Ai 1.36µmol/cm3
k2 174 1/h α 0.673 σ C0Ai/(C0K )η
γ 0.44 η 1.5
Fig. 1 Sensitivity analysis for



























































dextran), we refer to [16]. Finally, the spatial convergence
behaviour of the mixed finite element discretization is inves-
tigated for the model problem (3.22). This is done in order
analyse the sharpness of the error estimate (3.30). We note
that the numerical simulations that are presented in the sequel
cover only a small range of our performed parameter sensi-
tivity and model validation studies.
We first analyze the sensitivity of our model with
respect to the parameter α. Simulations were done for α =
0.6, 0.673, 0.8, 1.0. The calculated percentage of degraded
collagen versus time is visualized in the left plot of Fig. 1. The
experimentally measured data (cf. [16] for details) are given
by the points with red squares. We conclude from this plot
that even small variations of the value of α lead to completely
different collagen degradation profiles. Thus, our model is
sensitive with respect to the parameter α that should be speci-
fied carefully for the respectively used collagenous material.
Moreover, the curves show that the simplest choice α = 1
does not lead to a sufficiently accurate description of the
degradation process.
Next, we study the sensitivity of our model with respect to
the parameter γ characterizing the degree of nonlinearity in
the cleavage process. In the right plot of Fig. 1 the calculated
percentage of degraded collagen versus time is visualized
for γ = 0.44, 0.6, 1.0. In the literature (cf. [10,12,23,24]),
the parameter γ is usually chosen equal to 1.0. However,
there is no experimental evidence for this choice. On the
contrary, our experimental results (cf. Fig. 1) show that the
degradation of collagen runs much faster at the initial stage,
when the enzyme concentration in the matrix is still relatively
low. This observation actually motivated us to describe the
cleavage of the collagen fibers in terms of a nonlinear model
by equipping CE S on the right-hand sides of (2.3), (2.4) and
(2.6) with an extra power γ in order to get more flexibility.
In the right plot of Fig. 1 we observe that the slopes of the
curves change substantially under variation of γ . Thus, this
parameter also has to be chosen carefully for the respectively
used collagenous material.
The next study is devoted to the influence of the radius and
of the height of a bacillary drug delivery system on the col-
lagen degradation and drug release process. We performed
both, two and three dimensional simulations. The reference
matrix has a radius of 0.139 cm and a height of 1.35 cm which
were determined by measurements; cf. [16]. First, we perfor-
med two-dimensional simulations by considering a transver-
sal cross section of the cylindrical matrix. Computations were
done for the radius being equal to 0.139 cm, for halved radius
and, finally, for doubled radius. The calculated percentage of
degraded collagen and released drug are visualized in Fig. 2.
Eventhough the differences between the considered matrix
systems are not really large, we note that at least at the initial
stage a smaller radius leads to a faster degradation of the col-
lagen matrix and a faster drug delivery which is an important
qualitative observation for the design, optimization and in
vivo application of collagenous drug delivery systems.
Next, we analyze the impact of the matrix height on the
degradation and release profiles. Three-dimensional simu-
lations were done for matrices of radius equal to 0.139 cm
and of height equal to 1.35, 2.27 and 4.54 cm. The calculated
results are visualized in the left plot of Fig. 3. A significant
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Fig. 2 Sensitivity analysis for
the radius of the matrix: two

























































Fig. 3 Sensitivity analysis for
the height of the matrix by three
dimensional computations (left)





















































dependence of the degradation profile on the matrix height
is not observed. Moreover, the three-dimensional calculation
predicts almost the same degradation profiles for the colla-
gen matrix as they are obtained by two-dimensional calcu-
lations. This is shown in the right plot of Fig. 3. Thus, the
matrix height and longitudinal effects do not seem to perturb
the collagen degradation and drug delivery significantly. The
degradation and release profiles that we obtained by three-
dimensional computations for halved and doubled radius are
almost the same as in the two-dimensional case (cf. Fig. 2)
and, therefore, not given here.
The last sensitivity study is concerned with the influence
of the parameter η on the drug release profile. This parame-
ter describes the nonlinear dependence of the immobilized
concentration of drug on the concentration of collagen [cf.
(2.11)]. In practice, the parameter η has to be fixed for the res-
pective collagenous material by least-squares fitting. For the
considered material (cf. Table 1) the best parameter fit was
obtained for η = 1.5; cf. [16]. In Fig. 4 a relatively strong
sensitivity of the calculated drug release profile with respect
to the model parameter η is observed. Increasing numbers of
η lead to a faster drug release; cf. Fig. 4.
Finally, for illustration purposes the calculated collagen
and drug concentration profiles of a two-dimensional simu-
lation (transversal cross section of a bacillary drug delivery
system) are visualized in Fig. 5. For the computations we





























Fig. 4 Sensitivity analysis for the model parameter η
We end this section with an analysis of the numerical
convergence rate of the mixed finite element discretization
(3.27), (3.28) of our model problem (3.22). Thereby, we shall
investigate the sharpness of the error estimate (3.30). We
choose the parametrization r(u) = u1/m with m ∈ N, m > 1.
Thus, problem (3.22) reads as
− ∆c + c1/m = f in Ω = [0, 1]2, c = 0 on ∂Ω.
(4.1)
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Fig. 5 Calculated collagen
(top) and drug (bottom) profiles
at time T = 240 min (left),
300 min (center) and 360 min
(right) of a two-dimensional
simulation (transversal cross












Table 2 Test for convergence
with Hölder–continuous
nonlinearity r(cε) = c1/mε ,
m = 2 and regularization
parameter ε = 10−14
h
√〈r(cε) − r(cε,h), cε − cε,h〉 Red ‖qε − qε,h‖L2(Ω) Red
1.00e-1 7.3601569e-03 – 1.0793323e-02 –
5.00e-2 3.6884238e-03 1.99 5.4532018e-03 1.98
2.50e-2 1.8451715e-03 2.00 2.7387057e-03 1.99
1.25e-2 9.2268223e-04 2.00 1.3716356e-03 2.00
6.25e-3 4.6134846e-04 2.00 6.8621731e-04 2.00
Table 3 Test for convergence
with Hölder–continuous
nonlinearity r(cε) = c1/mε ,
m = 4 and regularization
parameter ε = 10−14
h
√〈r(cε) − r(cε,h), cε − cε,h〉 Red ‖qε − qε,h‖L2(Ω) Red
1.00e-1 1.1189781e-02 – 1.1075110e-02 –
5.00e-2 5.6485600e-03 1.98 5.4665501e-03 2.02
2.50e-2 2.8344437e-03 1.99 2.7331187e-03 2.00
1.25e-2 1.4190860e-03 2.00 1.3712282e-03 1.99
6.25e-3 7.0987767e-04 2.00 6.9221081e-04 1.98
We consider a solution c of (4.1) that is given by
c(x, y) = x(1 − x)y(1 − y). (4.2)
However, for this function c the nonlinear Newton solver
fails to convergence due to the unboundedness of r ′(c) =
1
m
c(1−m)/m . Therefore, we still regularize c by prescribing,
instead of c, the solution
cε(x, y) = ε + x(1 − x)y(1 − y), with 1  ε > 0. (4.3)
For cε we compute the corresponding right-hand side
function fε by means of (4.1), then we solve the mixed sys-
tem of Eqs. (3.27), (3.28) for the thus obtained function fε
and, finally, we compare the computed mixed finite element
approximation with (4.3). Of course, the non-vanishing Diri-
chlet boundary values of cε still have to be incorporated in
(3.27), (3.28) in a standard way; cf. [5]. We study the either
cases m = 2 and m = 4. The calculated errors and error
reduction factors, i.e., the ratios of the errors calculated for
h and h/2 respectively, for a sequence of mesh sizes are sum-
marized in Tables 2 and 3. In each mesh refinement step we
reduce the mesh size h by a factor of 2.
In Tables 2 and 3 we observe an optimal first-order conver-
gence behaviour of the mixed finite element discretization
(3.27), (3.28) which would argue for the non-sharpness of our
error estimate (3.30). However, we conjecture that the regu-
larization (4.3) oversimplifies the test problem since r ′(cε) ≤
r ′(ε), with r ′(c) = c(1/m)−1/m, is bounded from above whe-
reas r ′(c) becomes unbounded for vanishing values of c. Pre-
cisely, the regularization (4.3) makes the nonlinearity r(cε)
Lipschitz continuous, i.e.,
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Table 4 Test for convergence
with Hölder–continuous
nonlinearity r(cε) = c1/mε ,
m = 2 and regularization
parameter ε = h
h
√〈r(cε) − r(cε,h), cε − cε,h〉 Red ‖qε − qε,h‖L2(Ω) Red
1.00e-1 3.8458094e-03 – 1.0814056e-02 –
5.00e-2 2.2116069e-03 1.74 5.4661357e-03 1.97
2.50e-2 1.2477231e-03 1.77 2.7420888e-03 1.99
1.25e-2 6.8900261e-04 1.81 1.3723620e-03 2.00
Table 5 Test for convergence
with Hölder–continuous
nonlinearity r(cε) = c1/mε ,
m = 4 and regularization
parameter ε = h
h
√〈r(cε) − r(cε,h), cε − cε,h〉 Red ‖qε − qε,h‖L2(Ω) Red
1.00e-1 3.5500634e-03 – 1.0813337e-02 –
5.00e-2 2.1912031e-03 1.62 5.4660022e-03 1.98
2.50e-2 1.3165121e-03 1.66 2.7420423e-03 1.99
1.25e-2 7.6773342e-04 1.71 1.3723438e-03 2.00
|r(cε) − r(c˜ε)| ≤ L|cε − c˜ε|
for all cε, c˜ε satisfying cε, c˜ε ≥ ε with Lipschitz constant
L = ε(1/m)−1/m. In such a case, by a small modification of
the proof of Theorem 2 the error bound









Due to the estimate (4.4), we conjecture that the conver-
gence behavior of the considered mixed finite element
approach is actually determined by the term h2/ε1−1/m . To
analyze this numerically, we repeat the previous convergence
test, but now with choosing ε = h instead of ε = 10−14 as
done in Tables 2 and 3. Thus, for the square root of the left-
hand side of (4.4) we may expect the order of convergence
3/4 if m = 2 and 5/8 if m = 4 and the error reduction
factors 23/4 ≈ 1.68 and 25/8 ≈ 1.54, respectively. The cal-
culated errors and reduction factors for a sequence of mesh
sizes are summarized in Tables 4 and 5. In fact, the results of
Tables 4 and 5, more precisely
√〈r(cε) − r(cε,h), cε − cε,h〉,
argue for a non-optimal convergence behavior of the conside-
red mixed finite element approach which however is slightly
better than it can be expected from the error estimate (4.4)
with ε = h. The reduction factors increase for h → 0 which
might be due to the fact that the function c in (4.2) vanishes
on the boundary of the unit square only and that the boundary
layer or the singular behavior of r ′(c) on ∂Ω is resolved bet-
ter for h → 0. Nevertheless, the calculated errors of Tables 4
and 5 clearly confirm a non-optimal convergence behavior of
lowest-order Raviart–Thomas mixed finite element approxi-
mations of boundary value problems having reactive terms
with unbounded derivative, as it is implied by Theorem 2.
5 Conclusions
In this paper a mathematical model describing enzymatic
degradation of collagenous drug delivery systems and simul-
taneous drug release was proposed. Existence and unique-
ness of a solution of the model equations could be ensured.
The mixed finite element approximation of the mathema-
tical model was analyzed theoretically and numerically. In
particular, a new error estimate of suboptimal order for reac-
tive terms with unbounded derivative was proved. A sen-
sitivity study was performed for the empirical parameters
of the model equations and further parameters that are of
importance for the application of the drug delivery systems
in practice. The numerically calculated data were carefully
compared with experimentally determined data. A good cor-
relation between the either data was observed which shows
the capability of the mathematical model to describe relia-
bly enzymatic matrix degradation and simultaneous drug
delivery.
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